Molecular Classification
Enzyme, Hydrolase, Serine hydrolase
Other Names
AmpC beta-lactamase, Cephalosporinase
Disease Roles
InfectionAntibiotic resistance

Beta-lactamase Class C Overview

Class C β-lactamases, also known as AmpC β-lactamases or cephalosporinases, are enzymes produced by many Gram-negative bacteria that confer resistance to a broad range of β-lactam antibiotics. These enzymes hydrolyze the amide bond in the β-lactam ring of antibiotics, rendering them ineffective. They are serine hydrolases, utilizing a serine residue to attack and hydrolyze the β-lactam ring. AmpC beta-lactamases are not inhibited by classic inhibitors such as clavulanic acid, sulbactam, or tazobactam; some newer inhibitors like avibactam can inhibit AmpC enzymes. These enzymes are a major cause of resistance to extended-spectrum cephalosporins in clinical isolates.

Mechanism of Action

Hydrolyzes the beta-lactam ring of antibiotics, rendering them inactive.

Biological Functions

Antibiotic resistance
Hydrolysis of beta-lactam antibiotics

Disease Associations

Infection
Antibiotic resistance

Safety Considerations

  • Contributes to antibiotic resistance, leading to treatment failures.
  • Poor inhibition by traditional beta-lactamase inhibitors necessitates use of alternative antibiotics or newer inhibitor combinations.

Interacting Drugs

Penicillins
Cephalosporins
Cefoxitin
Avibactam
Clavulanic acid
Sulbactam
Tazobactam